Bionik Laboratories Corp. announced that on August 30, 2022, Gerald Malone, an independent director of the Company, as well as the Chairman of its Compensation Committee and a member of its Audit Committee, resigned from all such positions with the Company. Mr. Malone's resignation as a director was not due to a disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -100.00% | -100.00% |
2023 | Bionik Laboratories Corp. Announces Executive Changes | CI |
2023 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-100.00% | 12 | |
-4.98% | 18TCr | |
+2.84% | 11TCr | |
-2.68% | 6.79TCr | |
+4.53% | 5.01TCr | |
+8.00% | 4.43TCr | |
+9.39% | 4.04TCr | |
+25.30% | 3.2TCr | |
-0.17% | 2.58TCr | |
+17.27% | 2.53TCr |
- Stock Market
- Equities
- BNKL Stock
- News Bionik Laboratories Corp.
- Bionik Laboratories Corp. Announces Resignation of Gerald Malone as Independent Director as Well as Chairman of Its Compensation Committee and Member of Its Audit Committee